| Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study LS Granfeldt Østgård, BC Medeiros, H Sengeløv, M Nørgaard, ... Journal of Clinical Oncology 33 (31), 3641-3649, 2015 | 436 | 2015 |
| Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study LSG Østgård, JM Nørgaard, H Sengeløv, M Severinsen, LS Friis, ... Leukemia 29 (3), 548-555, 2015 | 84 | 2015 |
| Reasons for treating secondary AML as de novo AML LSG Østgård, E Kjeldsen, MS Holm, PDN Brown, BB Pedersen, K Bendix, ... European journal of haematology 85 (3), 217-226, 2010 | 69 | 2010 |
| Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities L Möllgård, L Saft, MB Treppendahl, I Dybedal, JM Nørgaard, J Astermark, ... Haematologica 96 (7), 963, 2011 | 68 | 2011 |
| Data quality in the Danish National Acute Leukemia Registry: a hematological data resource LSG Østgård, JM Nørgaard, MT Severinsen, H Sengeløv, L Friis, ... Clinical epidemiology, 335-344, 2013 | 61 | 2013 |
| Biology of multiple drug resistance in acute leukemia JM Norgaard, P Hokland International journal of hematology 72 (3), 290-297, 2000 | 58 | 2000 |
| Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling LH Olesen, A Aggerholm, BL Andersen, CG Nyvold, P Guldberg, ... British journal of haematology 131 (4), 457-467, 2005 | 56 | 2005 |
| Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases C Veigaard, JM Nørgaard, E Kjeldsen Cancer genetics 204 (9), 516-521, 2011 | 50 | 2011 |
| MDR1 gene expression and drug resistance of AML cells JM NØrgaard, A Bukh, S Tyge Langkjer, N Clausen, T Palshof, P Hokland British journal of haematology 100 (3), 534-540, 1998 | 49 | 1998 |
| Relation of blast cell survival and proliferation to chemotherapy resistance in AML JM NØrgaard, ST Langkjer, T Palshof, N Clausen, B Pedersen, P Hokland British journal of haematology 93 (4), 888-897, 1996 | 45 | 1996 |
| Validation and clinical implication of a quantitative real‐time PCR determination of MDR1 gene expression: comparison with semi‐quantitative PCR in 101 patients with acute … LH Olesen, JM Nørgaard, N Pallisgaard, A Bukh, P Hokland European journal of haematology 70 (5), 296-303, 2003 | 43 | 2003 |
| Changing picture of cellular drug resistance in human leukemia JM Nørgaard, LH Olesen, P Hokland Critical reviews in oncology/hematology 50 (1), 39-49, 2004 | 40 | 2004 |
| Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: a national population-based cohort study LSG Østgård, M Nørgaard, BC Medeiros, LS Friis, C Schoellkopf, ... Journal of Clinical Oncology 35 (32), 3678-3687, 2017 | 39 | 2017 |
| Impact of allogeneic stem cell transplantation in first complete remission in acute myeloid leukemia: a national population-based cohort study LSG Østgård, JL Lund, JM Nørgaard, M Nørgaard, BC Medeiros, ... Biology of Blood and Marrow Transplantation 24 (2), 314-323, 2018 | 35 | 2018 |
| Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia T Silkjaer, JM Nørgaard, A Aggerholm, LH Ebbesen, E Kjeldsen, ... European journal of haematology 90 (5), 385-396, 2013 | 34 | 2013 |
| The Danish national acute leukemia registry LSG Østgård, JM Nørgaard, KK Raaschou-Jensen, RS Pedersen, ... Clinical epidemiology, 553-560, 2016 | 32 | 2016 |
| Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies B Pedersen, JM Nørgaard, BB Pedersen, N Clausen, IH Rasmussen, ... American journal of hematology 64 (3), 161-169, 2000 | 32 | 2000 |
| Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia JM Nørgaard, ST Langkjer, T Palshof, B Pedersen, P Hokland European journal of haematology 66 (3), 160-167, 2001 | 28 | 2001 |
| FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara‐C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia JM Nørgaard, LH Olesen, G Olesen, K Meyer, JS Kristensen, K Bendix, ... European journal of haematology 67 (4), 221-229, 2001 | 27 | 2001 |
| Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the Nordic countries L Wennström, PW Edslev, J Abrahamsson, JM Nørgaard, Y Fløisand, ... Pediatric Blood & Cancer 63 (1), 83-92, 2016 | 26 | 2016 |
